Nunzia Pharmaceutical Corp. (NUNZ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Nunzia Pharmaceutical Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2022 | -0.9582 |
| June 30, 2022 | -1.192 |
| March 31, 2022 | -1.001 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.2999 |
| March 31, 2021 | -0.3063 |
| December 31, 2020 | -0.3872 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| September 30, 2018 | |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2009 | -0.503 |
| September 30, 2009 | -0.497 |
| June 30, 2009 | -0.4925 |
| March 31, 2009 | -0.488 |
| December 31, 2008 | -0.4846 |
| September 30, 2008 | -0.48 |
| June 30, 2008 | -0.4753 |
| Date | Value |
|---|---|
| March 31, 2008 | -0.4704 |
| December 31, 2007 | -0.4653 |
| September 30, 2007 | -0.4592 |
| June 30, 2007 | -0.456 |
| March 31, 2007 | -0.4513 |
| December 31, 2006 | -0.4462 |
| September 30, 2006 | -0.4414 |
| June 30, 2006 | -0.4365 |
| March 31, 2006 | -0.4318 |
| December 31, 2005 | -0.4273 |
| September 30, 2005 | -0.4996 |
| June 30, 2005 | -0.6037 |
| March 31, 2005 | -0.7574 |
| December 31, 2004 | -0.2218 |
| September 30, 2004 | -0.4598 |
| June 30, 2004 | -0.4552 |
| March 31, 2004 | -0.4747 |
| December 31, 2003 | -0.4639 |
| September 30, 2003 | 0.3216 |
| June 30, 2003 | 0.1265 |
| March 31, 2003 | 0.00 |
| December 31, 2002 | -3.958 |
| September 30, 2002 | 2.023 |
| June 30, 2002 | 1.976 |
| March 31, 2002 | 1.627 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Herborium Group, Inc. | -0.2487 |
| Entia Biosciences, Inc. | -- |
| Trident Brands, Inc. | -- |
| Medifast, Inc. | 0.1406 |
| Joey New York, Inc. | -- |